{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:09:40Z","timestamp":1790500180778,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DST grant, India","award":["YSS\/2015\/000613"],"award-info":[{"award-number":["YSS\/2015\/000613"]}]},{"DOI":"10.13039\/501100011067","name":"Indian Institute of Technology Mandi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011067","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijbiomac.2017.06.105","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T22:46:09Z","timestamp":1498603569000},"page":"1046-1054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"PA","title":["Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein"],"prefix":"10.1016","volume":"104","author":[{"given":"Nitin","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthy","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajanish","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0005","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S1473-3099(16)30010-X","article-title":"Zika virus: history of a newly emerging arbovirus","volume":"16","author":"Wikan","year":"2016","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0010","first-page":"1386","article-title":"Evidence of sexual transmission of Zika virus","author":"D\u2019Ortenzio","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3201\/eid2102.141363","article-title":"Potential sexual transmission of Zika virus","volume":"21","author":"Musso","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1473-3099(16)30069-X","article-title":"Zika virus at the games: is it safe?","volume":"16","author":"The Lancet Infectious Diseases","year":"2016","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0025","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0030","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.stem.2016.02.016","article-title":"Zika virus infects human cortical neural progenitors and attenuates their growth","volume":"18","author":"Tang","year":"2016","journal-title":"Cell Stem Cell."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0040","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(16)31207-7","article-title":"The Zika virus public health emergency: 6 months on","volume":"388","author":"Maurice","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(16)00320-2","article-title":"Zika virus and microcephaly: why is this situation a PHEIC?","volume":"387","author":"Heymann","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0050","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1602412","article-title":"Zika virus infection in pregnant women in Rio de Janeiro\u2014preliminary report","author":"Brasil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0055","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/cid\/cix137","article-title":"Characteristics of Zika virus disease in children: clinical, hematological, and virological findings from an outbreak in Singapore","volume":"64","author":"Li","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0060","doi-asserted-by":"crossref","unstructured":"Areas with Risk of Zika | Zika virus | CDC, (n.d.). https:\/\/www.cdc.gov\/zika\/geo\/. (Accessed 11 May 2017).","DOI":"10.1093\/med\/9780190604813.003.0015"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.tibs.2017.02.009","article-title":"Structural biology of the Zika virus","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fcimb.2016.00144","article-title":"Intrinsically disordered side of the Zika virus proteome","volume":"6","author":"Giri","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0080","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/pro.2480","article-title":"The mechanism of binding of the KIX domain to the mixed lineage leukemia protein and its allosteric role in the recognition of c-Myb","volume":"23","author":"Toto","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0085","doi-asserted-by":"crossref","first-page":"21994","DOI":"10.1038\/srep21994","article-title":"Molecular recognition by templated folding of an intrinsically disordered protein","volume":"6","author":"Toto","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0090","article-title":"Therapeutic interventions of cancers using intrinsically disordered proteins as drug targets: c-Myc as model system","volume":"16","author":"Kumar","year":"2017","journal-title":"Cancer Inf."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/pro.2608","article-title":"Intrinsic disorder mediates hepatitis C virus core-host cell protein interactions","volume":"24","author":"Dolan","year":"2015","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fcimb.2017.00044","article-title":"Mutational pressure in Zika virus: local ADAR-editing areas associated with pauses in translation and replication","volume":"7","author":"Khrustalev","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0105","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microb."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0110","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrmicro1326","article-title":"Virus membrane-fusion proteins: more than one way to make a hairpin","volume":"4","author":"Kielian","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbrc.2012.09.112","article-title":"A folding-after-binding mechanism describes the recognition between the transactivation domain of c-Myb and the KIX domain of the CREB-binding protein","volume":"428","author":"Gianni","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0130","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1073\/pnas.1307337110","article-title":"Structure of the transition state for the binding of c-Myb and KIX highlights an unexpected order for a disordered system","volume":"110","author":"Giri","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.virol.2016.06.012","article-title":"The green tea molecule EGCG inhibits Zika virus entry","volume":"496","author":"Carneiro","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0140","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","author":"Sherman","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0145","unstructured":"Desmond-version 3.1. New York, NY: Schrodinger, LLC, 2012."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0150","doi-asserted-by":"crossref","first-page":"e0153999","DOI":"10.1371\/journal.pone.0153999","article-title":"A comprehensive In silico analysis on the structural and functional impact of SNPs in the congenital heart defects associated with NKX2-5 gene\u2014a molecular dynamic simulation approach","volume":"11","author":"Abdul Samad","year":"2016","journal-title":"PLoS One"},{"issue":"45","key":"10.1016\/j.ijbiomac.2017.06.105_bib0155","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0160","doi-asserted-by":"crossref","first-page":"e0121860","DOI":"10.1371\/journal.pone.0121860","article-title":"An In silico insight into novel therapeutic interaction of LTNF peptide-LT10 and design of structure based peptidomimetics for putative anti-diabetic activity","volume":"10","author":"Chavan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0165","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ijbiomac.2016.10.008","article-title":"Investigating the folding pathway and substrate induced conformational changes in B. malayi Guanylate kinase","volume":"94","author":"Gupta","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/10799893.2014.956756","article-title":"Assessment of dual inhibition property of newly discovered inhibitors against PCAF and GCN5 through in silico screening, molecular dynamics simulation and DFT approach","volume":"35","author":"Suryanarayanan","year":"2015","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0175","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1039\/C4MB00077C","article-title":"Insights into the structural basis of 3,5-diaminoindazoles as CDK2 inhibitors: prediction of binding modes and potency by QM-MM interaction MESP and MD simulation","volume":"10","author":"Tripathi","year":"2014","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0180","first-page":"1","article-title":"Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of mycobacterium tuberculosis isocitrate lyase","author":"Shukla","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0185","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/JVI.00596-11","article-title":"The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein","volume":"85","author":"Zheng","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.virol.2005.09.036","article-title":"Class II virus membrane fusion proteins","volume":"344","author":"Kielian","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0195","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41598-017-01235-z","article-title":"Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility","volume":"7","author":"Shukla","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0200","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/acsinfecdis.5b00066","article-title":"Flavivirus entry inhibitors","volume":"1","author":"Wang","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0205","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5483\/BMBRep.2008.41.6.444","article-title":"Modeled structure of trypanothione reductase of Leishmania infantum","volume":"41","author":"Singh","year":"2008","journal-title":"BMB Rep."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0210","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejpb.2013.08.014","article-title":"Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen","volume":"85","author":"Saudagar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0215","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd1331","article-title":"Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes","volume":"3","author":"Matthews","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(07)61052-6","article-title":"HIV. entry inhibitors","volume":"370","author":"Est\u00e9","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0225","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0230","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature17994","article-title":"Structure of the thermally stable Zika virus","volume":"7603","author":"Kostyuchenko","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.200507075","article-title":"Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion","volume":"171","author":"Liao","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0240","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.ppat.0030020","article-title":"Characterization of a structural intermediate of flavivirus membrane fusion","volume":"3","author":"Stiasny","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2012.10.009","article-title":"Limited sampling estimates of epigallocatechin gallate exposures in cirrhotic and noncirrhotic patients with hepatitis C after single oral doses of green tea extract","volume":"34","author":"Halegoua-De Marzio","year":"2012","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2017.06.105_bib0250","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1038\/emi.2016.3","article-title":"Entry inhibitors: new advances in HCV treatment","volume":"5","author":"Qian","year":"2016","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0255","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.2174\/1381612811319340008","article-title":"Tea and health: studies in humans","volume":"19","author":"Khan","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2017.06.105_bib0260","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.fct.2005.11.002","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats","volume":"44","author":"Isbrucker","year":"2006","journal-title":"Food Chem. Toxicol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017319025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017319025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T10:20:01Z","timestamp":1575627601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813017319025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":52,"alternative-id":["S0141813017319025"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.06.105","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.06.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}